Fennec Pharma

Fennec Pharma is a clinical-stage biotechnology company developing Sodium Thiosulfate (STS), a chemoprotective agent for platinum-induced hearing loss. STS is being evaluated in two Phase III pediatric studies to assess reduction in ototoxicity and impact on survival.